A critical advance in cancer investigation is emerging with the use of VHH fragments to reactivate dysfunctional p53. This crucial cancer protector protein is frequently disabled in various kinds of tumors, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research